Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
Study Details
Study Description
Brief Summary
Lead survivability will be summarized.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The purpose of this study is to evaluate long-term performance of the 4296 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4296 LV Lead. This study is conducted within Medtronic's post-market surveillance platform.
Study Design
Outcome Measures
Primary Outcome Measures
- Model 4296 LV Lead-related complication rate [5 years]
To demonstrate that the Model 4296 lead-related complication-free probability
Secondary Outcome Measures
- Types of lead-related adverse device effects [5 years]
To summarize all lead related adverse events
- Percent of subjects with changes in electrode programming [5 years]
To characterize any changes in electrical programming
- Number of fractures with and without loss of function [5 years]
To characterize fractures with and without loss of function
- Bipolar electrical performance at 1 year [1 year]
To summarize bipolar electrical performance at one year post implant
- Bipolar pacing impedance [1 year]
To characterize threshold measurements and impedance for both conductors
- Bipolar pacing capture threshold [1 year]
To characterize standard bipolar pacing voltage thresholds
Eligibility Criteria
Criteria
Patients who meet all of the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.
Inclusion Criteria
-
Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
-
Patient has or is intended to receive an Attain Ability Model 4296 LV lead
-
Patient within 30 day post implant enrollment window
Exclusion Criteria
-
Patient who is, or is expected to be inaccessible for follow-up
-
Patient with exclusion criteria required by local law
-
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Birmingham | Alabama | United States | 35294 | |
2 | Anchorage | Alaska | United States | 99508 | |
3 | Chandler | Arizona | United States | 85226 | |
4 | Gilbert | Arizona | United States | 85295 | |
5 | Phoenix | Arizona | United States | 85006 | |
6 | Jonesboro | Arkansas | United States | 72410 | |
7 | Little Rock | Arkansas | United States | 72205 | |
8 | Bakersfield | California | United States | 93309 | |
9 | Chula Vista | California | United States | 91910 | |
10 | Monterey | California | United States | 93940 | |
11 | Rancho Mirage | California | United States | 92270 | |
12 | Redding | California | United States | 96001 | |
13 | Redwood City | California | United States | 94062 | |
14 | Salinas | California | United States | 93901 | |
15 | San Diego | California | United States | 92103 | |
16 | San Francisco | California | United States | 94143 | |
17 | Stanford | California | United States | 94305 | |
18 | Torrance | California | United States | 90503 | |
19 | Van Nuys | California | United States | 91405 | |
20 | Colorado Springs | Colorado | United States | 80907 | |
21 | Lakewood | Colorado | United States | 80228 | |
22 | New Haven | Connecticut | United States | 06519 | |
23 | Newark | Delaware | United States | 19713 | |
24 | Washington | District of Columbia | United States | 20010 | |
25 | Bradenton | Florida | United States | 34205 | |
26 | Clearwater | Florida | United States | 33756 | |
27 | Jacksonville | Florida | United States | 32216 | |
28 | Melbourne | Florida | United States | 32901 | |
29 | Safety Harbor | Florida | United States | 34695 | |
30 | Tampa | Florida | United States | 33607 | |
31 | Indianapolis | Indiana | United States | 46202 | |
32 | West Des Moines | Iowa | United States | 50266 | |
33 | Kansas City | Kansas | United States | 66160 | |
34 | Lexington | Kentucky | United States | 40503 | |
35 | Louisville | Kentucky | United States | 40207 | |
36 | Baton Rouge | Louisiana | United States | 70808 | |
37 | New Orleans | Louisiana | United States | 70121 | |
38 | Hyattsville | Maryland | United States | 20782 | |
39 | Silver Spring | Maryland | United States | 20910 | |
40 | Takoma Park | Maryland | United States | 20912 | |
41 | Worcester | Massachusetts | United States | 01605 | |
42 | Lansing | Michigan | United States | 48912 | |
43 | Marquette | Michigan | United States | 49855 | |
44 | Ypsilanti | Michigan | United States | 48197 | |
45 | Robbinsdale | Minnesota | United States | 55422 | |
46 | Rochester | Minnesota | United States | 55905 | |
47 | Saint Louis Park | Minnesota | United States | 55416 | |
48 | Columbia | Missouri | United States | 65201 | |
49 | Kansas City | Missouri | United States | 64111 | |
50 | Saint Louis | Missouri | United States | 63110 | |
51 | Henderson | Nevada | United States | 89052 | |
52 | Las Vegas | Nevada | United States | 89169 | |
53 | Lebanon | New Hampshire | United States | 03766 | |
54 | Morristown | New Jersey | United States | 07960 | |
55 | Ocean City | New Jersey | United States | 07712 | |
56 | West Orange | New Jersey | United States | 07052 | |
57 | Albuquerque | New Mexico | United States | 87106 | |
58 | Garden City | New York | United States | 11530 | |
59 | Huntington | New York | United States | 11743 | |
60 | New York | New York | United States | 10016 | |
61 | Poughkeepsie | New York | United States | 12601 | |
62 | Utica | New York | United States | 13501 | |
63 | Durham | North Carolina | United States | 27705 | |
64 | Greensboro | North Carolina | United States | 27610 | |
65 | Winston-Salem | North Carolina | United States | 27157 | |
66 | Fargo | North Dakota | United States | 58122 | |
67 | Akron | Ohio | United States | 44304 | |
68 | Cincinnati | Ohio | United States | 45219 | |
69 | Cleveland | Ohio | United States | 44195 | |
70 | Toledo | Ohio | United States | 43608 | |
71 | Allentown | Pennsylvania | United States | 18103 | |
72 | Danville | Pennsylvania | United States | 17822 | |
73 | Erie | Pennsylvania | United States | 16550 | |
74 | Lancaster | Pennsylvania | United States | 17604 | |
75 | Philadelphia | Pennsylvania | United States | 19104 | |
76 | Pittsburgh | Pennsylvania | United States | 15213 | |
77 | Wilkes-Barre | Pennsylvania | United States | 18711 | |
78 | Columbia | South Carolina | United States | 29204 | |
79 | Germantown | Tennessee | United States | 38138 | |
80 | Kingsport | Tennessee | United States | 37660 | |
81 | Nashville | Tennessee | United States | 37203 | |
82 | Austin | Texas | United States | 78705 | |
83 | Dallas | Texas | United States | 75226 | |
84 | Houston | Texas | United States | 77030 | |
85 | Plano | Texas | United States | 75093 | |
86 | San Antonio | Texas | United States | 78229 | |
87 | The Woodlands | Texas | United States | 77384 | |
88 | Falls Church | Virginia | United States | 22042 | |
89 | Leesburg | Virginia | United States | 20176 | |
90 | Olympia | Washington | United States | 98506 | |
91 | Spokane | Washington | United States | 99204 | |
92 | Tacoma | Washington | United States | 98402 | |
93 | Madison | Wisconsin | United States | 53715 | |
94 | Milwaukee | Wisconsin | United States | 53215 | |
95 | Ottawa | Ontario | Canada | K1Y 4W7 | |
96 | Peterborough | Ontario | Canada | K9J 0B2 | |
97 | Montreal | Quebec | Canada | H2W 1T8 | |
98 | Quebec | Canada | G1V 4G5 | ||
99 | Essen | Germany | 45147 |
Sponsors and Collaborators
- Medtronic
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 4296 Chronic Performance